MedTrace Logo

Ultrasound Findings in Diabetic Pregnancies

NCT06407388 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2024-05-09

No results posted yet for this study

Summary

The goal of our study is to identify ultrasonographic markers that can predict adverse neonatal outcomes. Specifically, we hypothesize that an increase in fetal liver volumes will increase transcutaneous bilirubin (TcB) in the newborn and thus jaundice requiring phototherapy. This information can be used in patient counseling and to guide future screening protocols for ultrasound in individuals with diabetes.

Conditions

Sponsors & Collaborators

  • Eastern Virginia Medical School

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2025-01-01
Completion
2025-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06407388 on ClinicalTrials.gov